Eggener SE, Berlin A, Vickers AJ, Paner GP, Wolinsky H, Cooperberg MR. Low-grade prostate cancer: time to stop calling it cancer. J Clin Oncol. 2022;40(27):3110-3114. DOI: https://ascopubs.org/doi/10.1200/JCO.22.00123

Labbate CV, Paner GP, Eggener SE. Should Grade Group 1 (GG1) be called cancer? World J Urol. 2022;40(1):15-19. DOI: https://link.springer.com/article/10.1007/s00345-020-03583-4

Epstein JI, Kibel AS. Renaming Gleason score 6 prostate to noncancer: A flawed idea scientifically and for patient care. J Clin Oncol. 2022;40(27):3106-3109. DOI: https://ascopubs.org/doi/10.1200/JCO.22.00926

Iczkowski KA, Molina M, Egevad L, Bostwick DG, van Leenders GLJLH, La Rosa FG, et al. Low-grade prostate cancer should still be labeled cancer. BJU Int. 2022. DOI: https://bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bju.15886

Netto GJ, Amin MB, Compérat EM, Gill AJ, Hartmann A, Moch H, et al. Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification. Eur Urol. 2022;S0302-2838(22)02644-6. DOI: https://doi.org/10.1016/j.eururo.2022.09.015

Alam MU, Kumar J, Norez D, Woolfe J, Tanneru K, Jazayeri SB, et al. Natural history, and impact of surgery and radiation on survival outcomes of men diagnosed with low-grade prostate cancer at ≤ 55 years of age: a 25-year follow-up of > 60,000 men. Int Urol Nephrol. 2022; 29 de septiembre. DOI: https://doi.org/10.1007/s11255-022-03363-6

Thomsen FB, Westerberg M, Garmo H, Robinson D, Holmberg L, Ulmert HD, et al. Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason grade: nationwide, population-based register study. PLoS One. 2020;15(1):e0228447. DOI: https://doi.org/10.1371/journal.pone.0228447

Le Bihan E, Derman J, Salomon L, De La Taille A, Irani J, Lebacle C. Radical prostatectomy in patients with Gleason 6 (ISUP 1) prostate cancer: 10-year follow up. Prog Urol. 2022;32(2):108-14. DOI: https://doi.org/10.1016/j.purol.2021.10.008

Naik N, Tokas T, Shetty DK, Hameed BMZ, Shastri S, Shah MJ, et al. Role of Deep Learning in Prostate Cancer Management: Past, Present and Future Based on a Comprehensive Literature Review. J Clin Med. 2022;11(13):3575. DOI: https://doi.org/10.3390/jcm11133575

Hurtado de Mendoza Amat JD, Montero González TJ. El diagnóstico correcto de las causas de muerte ayuda a salvar vidas. Revista Cubana de Medicina Militar. 2020 [acceso 12/10/2022];49(4):e0200629. Disponible en: http://www.revmedmilitar.sld.cu/index.php/mil/article/view/629